Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022
June 27th 2022Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.
Read More
Patients With Metastatic Breast Cancer Should Be in the Driver's Seat for Their Treatment Planning
June 23rd 2022In CURE®’s “Speaking Out” video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for brain metastases in breast cancer and how patients can take part in driving their care.
Read More
Educated Patient® Kidney Cancer Summit Panel on Immunotherapy/TKI Combo Treatment: April 9, 2022
April 25th 2022Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss the treatment of combining immunotherapy with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.
Read More